<DOC>
	<DOCNO>NCT00710294</DOCNO>
	<brief_summary>This clinical investigation design describe long-term safety efficacy CVRx Rheos Baroreflex Hypertension Therapy System patient participate DEBuT-HT study beyond original follow period ( 4-months longer ) . The information obtain trial intend support regulatory approval market release therapy .</brief_summary>
	<brief_title>Device Based Therapy Hypertension Extension Trial</brief_title>
	<detailed_description>This extension study , design long-term follow , monitor course disease treatment safety efficacy collect appropriate data use data collect long term provision DEBuT-HT study describe analyze change ongoing drug treatment , program parameter implant active device occur adverse event period 13 month implant surgery DEBuT-HT trial . Annual follow-ups five year plan subsequently 13-month follow-up period .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Have complete followup period ( 4month longer ) DEBuTHT trial ( protocol No . : 360004001 ) Have sign approve informed consent form participation study Are unable comply protocol requirement . Are enrol another concurrent clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Refractory Hypertension</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Uncontrolled Blood Pressure</keyword>
</DOC>